US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist
  • 1.150
  • +0.035+3.14%
Close Oct 2 16:00 ET
  • 1.150
  • 0.0000.00%
Post 18:50 ET
63.54MMarket Cap-2500P/E (TTM)

Vivani Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-18.88%5.68M
-5.67%6.23M
26.95%26.97M
-20.19%6.22M
31.23%7.14M
71.35%7M
68.95%6.6M
59.43%21.24M
119.56%7.79M
56.21%5.44M
Selling and administrative expenses
-30.93%2.17M
-5.48%2.5M
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
156.89%1.59M
-General and administrative expense
-30.93%2.17M
-5.48%2.5M
41.36%10M
-55.13%1.51M
70.54%2.7M
255.09%3.14M
115.47%2.65M
204.70%7.07M
486.91%3.36M
156.89%1.59M
Research and development costs
-9.08%3.51M
-5.79%3.73M
19.75%16.97M
6.35%4.71M
15.08%4.44M
20.64%3.86M
47.63%3.96M
28.79%14.17M
48.81%4.43M
34.55%3.86M
Operating profit
18.88%-5.68M
5.67%-6.23M
-26.95%-26.97M
20.19%-6.22M
-31.23%-7.14M
-71.35%-7M
-68.95%-6.6M
-59.43%-21.24M
-119.56%-7.79M
-56.21%-5.44M
Net non-operating interest income expense
Other net income (expense)
-31.87%325K
-33.57%188K
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
114,550.00%6.87M
Other non- operating income (expenses)
-31.87%325K
-33.57%188K
-82.14%1.31M
-62.25%191K
-94.73%362K
3,081.25%477K
1,764.71%283K
1,236.73%7.35M
802.78%506K
114,550.00%6.87M
Income before tax
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
Income tax
Net income
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
Net income continuous Operations
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
Minority interest income
Net income attributable to the parent company
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.05%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
140.76%1.42M
Basic earnings per share
23.08%-0.1
0.00%-0.12
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
137.92%0.04
Diluted earnings per share
23.08%-0.1
0.00%-0.12
-38.89%-0.5
38.89%-0.11
-425.00%-0.13
-60.72%-0.13
-1.20%-0.12
7.69%-0.36
-64.55%-0.18
137.92%0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -18.88%5.68M-5.67%6.23M26.95%26.97M-20.19%6.22M31.23%7.14M71.35%7M68.95%6.6M59.43%21.24M119.56%7.79M56.21%5.44M
Selling and administrative expenses -30.93%2.17M-5.48%2.5M41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M156.89%1.59M
-General and administrative expense -30.93%2.17M-5.48%2.5M41.36%10M-55.13%1.51M70.54%2.7M255.09%3.14M115.47%2.65M204.70%7.07M486.91%3.36M156.89%1.59M
Research and development costs -9.08%3.51M-5.79%3.73M19.75%16.97M6.35%4.71M15.08%4.44M20.64%3.86M47.63%3.96M28.79%14.17M48.81%4.43M34.55%3.86M
Operating profit 18.88%-5.68M5.67%-6.23M-26.95%-26.97M20.19%-6.22M-31.23%-7.14M-71.35%-7M-68.95%-6.6M-59.43%-21.24M-119.56%-7.79M-56.21%-5.44M
Net non-operating interest income expense
Other net income (expense) -31.87%325K-33.57%188K-82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K114,550.00%6.87M
Other non- operating income (expenses) -31.87%325K-33.57%188K-82.14%1.31M-62.25%191K-94.73%362K3,081.25%477K1,764.71%283K1,236.73%7.35M802.78%506K114,550.00%6.87M
Income before tax 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M
Income tax
Net income 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M
Net income continuous Operations 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M
Minority interest income
Net income attributable to the parent company 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.05%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M140.76%1.42M
Basic earnings per share 23.08%-0.10.00%-0.12-38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18137.92%0.04
Diluted earnings per share 23.08%-0.10.00%-0.12-38.89%-0.538.89%-0.11-425.00%-0.13-60.72%-0.13-1.20%-0.127.69%-0.36-64.55%-0.18137.92%0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data